<DOC>
	<DOCNO>NCT03003884</DOCNO>
	<brief_summary>The purpose study find optimal dose Remimazolam Tosilate procedural sedative diagnostic upper GI endoscopy ass efficacy safety profile compare propofol .</brief_summary>
	<brief_title>A Study Remimazolam Tosilate Patients Undergoing Diagnostic Upper GI Endoscopy</brief_title>
	<detailed_description>This multi-center , single-blinded , parallel-group , dose-finding study use Remimazolam propofol sedation patient undergoing diagnostic upper GI endoscopy.Subjects randomize different treatment group ( include 4 Remimazolam Tosilate 1 propofol ) .Lidocaine fentanyl permit diagnostic upper GI endoscopy.Efficacy safety profile Remimazolam Tosilate evaluate .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>subject age 1860 years； intend undergo diagnostic upper GI endoscopy ASA ( American Society Anesthesiologists ) I II； 18 kg/m² &lt; BMI ( Body Mass Index ) &lt; 30 kg/m² . Patients suspect upper GI bleed condition predispose hemorrhage discretion investigator ; one laboratory finding fall limitation study ( platelet , hemoglobin , aspartate aminotransferase , etc . ) ; history recent use narcotic , analgesic , anaesthetic benzodiazepine hypnotic ; history severe cardiovascular disease ; cerebral disease mental disorder ; allergic drug use study ; pregnant woman lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>